GILEAD SCIENCES, INC. (GILD)
Health Care / Biotechnology
$144.93
Above average across most dimensions. A solid candidate.
Buy
Score based on 4 of 5 models — moderate confidence
Key Metrics
Estimated Fair Value
Fair value above market price. EPS grew 1673% year-over-year. ROE of 38% signals strong profitability. P/E of 21x is moderate for this quality level.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Strong
7/9
Buffett
Strong
Business quality & competitive moat
Graham
Caution
Significantly above fair value
Lynch
Neutral
Growth rate vs price (PEG)
Greenblatt
Attractive
Top 25% (rank 19%)
Similar Stocks
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer